NCT02329899View on ClinicalTrials.gov

Standardisation of Investigations of Mild Bleeding Disorders

CompletedOBSERVATIONAL
Enrollment

208

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Hemorrhagic Disorders
Interventions
OTHER

Second step of investigations

"Second step according to results of the first step:~* exploration of coagulation factors;~* factor XIII and fibrinolysis investigations;~* investigation of platelet function;~* investigation of thrombocytopenia."

Trial Locations (1)

1205

Haemostasis unit, University Hospitals of Geneva, Geneva

All Listed Sponsors
lead

University Hospital, Geneva

OTHER

NCT02329899 - Standardisation of Investigations of Mild Bleeding Disorders | Biotech Hunter | Biotech Hunter